Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2015

Open Access 01-12-2015 | Letter

Response to ‘Increase of nerve growth factor levels in the human herniated intervertebral disc: can annular rupture trigger discogenic back pain?’ – authors’ reply

Authors: Yasuchika Aoki, Arata Nakajima, Seiji Ohtori, Hiroshi Takahashi, Fusako Watanabe, Masato Sonobe, Fumiaki Terajima, Masahiko Saito, Kazuhisa Takahashi, Tomoaki Toyone, Atsuya Watanabe, Takayuki Nakajima, Makoto Takazawa, Koichi Nakagawa

Published in: Arthritis Research & Therapy | Issue 1/2015

Login to get access

Excerpt

We appreciate the interest and attention paid by Agilli and Ekinci, and we agree with their point that nerve growth factor (NGF) levels could be affected by multiple factors [1]. As pointed out, the paper would be improved by considering the effects of these factors; thus the data were re-examined. This analysis found that the number of patients who had neuropsychiatric diseases and use medications (one patient in the herniated group and two patients in the nonherniated group) and had diabetes mellitus (two patients in each group) were similar between the two groups. As Bullo and colleagues described, obesity is one of the important factors affecting NGF levels in blood samples [2]. These authors also indicated the influence of body mass index (BMI) on NGF levels; thus, the BMI of our patients was analyzed and included in the multivariate analysis. The BMI of the two groups showed no significant difference (24.0 ± 4.0 in the herniated group and 25.3 ± 3.2 in the nonherniated group, P = 0.20), and Pearson’s correlation analysis showed no significant correlation between the level of NGF and BMI (P = 0.91). The multivariate analysis adjusted for age, sex, disc degeneration and BMI still showed a significant correlation between disc herniation and NGF levels (P = 0.018). …
Literature
1.
go back to reference Agilli M, Ekinci S. Response to ‘Increase of nerve growth factor levels in the human herniated intervertebral disc: can annular rupture trigger discogenic back pain?’ Arthritis Res Ther. 2015. doi: 10.1186/s13075-015-0607-4 Agilli M, Ekinci S. Response to ‘Increase of nerve growth factor levels in the human herniated intervertebral disc: can annular rupture trigger discogenic back pain?’ Arthritis Res Ther. 2015. doi: 10.1186/s13075-015-0607-4
2.
go back to reference Bullo M, Peeraully MR, Trayhurn P, Folch J, Salas-Salvado J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. Eur J Endocrinol. 2007;157:303–10.CrossRefPubMed Bullo M, Peeraully MR, Trayhurn P, Folch J, Salas-Salvado J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. Eur J Endocrinol. 2007;157:303–10.CrossRefPubMed
3.
go back to reference Miyagi M, Ishikawa T, Orita S, Eguchi Y, Kamoda H, Arai G, et al. Disk injury in rats produces persistent increases in pain-related neuropeptides in dorsal root ganglia and spinal cord glia but only transient increases in inflammatory mediators: pathomechanism of chronic diskogenic low back pain. Spine. 2011;36:2260–6.CrossRefPubMed Miyagi M, Ishikawa T, Orita S, Eguchi Y, Kamoda H, Arai G, et al. Disk injury in rats produces persistent increases in pain-related neuropeptides in dorsal root ganglia and spinal cord glia but only transient increases in inflammatory mediators: pathomechanism of chronic diskogenic low back pain. Spine. 2011;36:2260–6.CrossRefPubMed
4.
go back to reference Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br. 2002;84:196–201.CrossRefPubMed Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br. 2002;84:196–201.CrossRefPubMed
5.
go back to reference Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MT, et al. Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol. 2002;197:286–92.CrossRefPubMed Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MT, et al. Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol. 2002;197:286–92.CrossRefPubMed
6.
go back to reference Urban JP, Smith S, Fairbank JC. Nutrition of the intervertebral disc. Spine (Phila Pa 1976). 2004;29:2700–9. Urban JP, Smith S, Fairbank JC. Nutrition of the intervertebral disc. Spine (Phila Pa 1976). 2004;29:2700–9.
Metadata
Title
Response to ‘Increase of nerve growth factor levels in the human herniated intervertebral disc: can annular rupture trigger discogenic back pain?’ – authors’ reply
Authors
Yasuchika Aoki
Arata Nakajima
Seiji Ohtori
Hiroshi Takahashi
Fusako Watanabe
Masato Sonobe
Fumiaki Terajima
Masahiko Saito
Kazuhisa Takahashi
Tomoaki Toyone
Atsuya Watanabe
Takayuki Nakajima
Makoto Takazawa
Koichi Nakagawa
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2015
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-015-0608-3

Other articles of this Issue 1/2015

Arthritis Research & Therapy 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.